Literature DB >> 18498063

Cyclooxygenases expression and distribution in the normal ovary and their role in ovarian cancer in the domestic hen (Gallus domesticus).

Dale Buchanan Hales1, Yan Zhuge, Jo Ann Jaen Lagman, Kristine Ansenberger, Cassandra Mahon, Animesh Barua, Judith L Luborsky, Janice M Bahr.   

Abstract

Cyclooxygenase (COX) (PTGS) is the rate-limiting enzyme in the biosynthesis of prostaglandins. Two COX isoforms have been identified, COX-1 and COX-2, which show distinct cell-specific expression and regulation. Ovarian cancer is the most lethal gynecological malignancy and the disease is poorly understood due to the lack of suitable animal models. The laying hen spontaneously develops epithelial ovarian cancer with few or no symptoms until the cancer has progresses to a late stage, similar to the human disease. The purpose of this study was to examine the relative expression and distribution of COX-1 and COX-2 in the ovaries of normal hens and in hens with ovarian cancer. The results demonstrate that COX-1 was localized to the granulosa cell layer and cortical interstitium, ovarian surface epithelium (OSE) and postovulatory follicle (POF) of the normal ovary. In ovarian cancer, COX-1 mRNA was significantly increased and COX-1 protein was broadly distributed throughout the tumor stroma. COX-2 protein was localized to the granulosa cell layer in the follicle and the ovarian stroma. COX-2 mRNA expression did not change as a function of age or in ovarian cancer. There was significantly higher expression of COX-1 mRNA in the first POF (POF-1) compared to POF-2 and POF-3. COX-2 mRNA expression was not significantly different among POFs. There was no difference in COX-1 or COX-2 mRNA in the OSE isolated from individual follicles in the follicular hierarchy. The results confirm previous findings of the high expression of COX-1 in ovarian tumors further supporting the laying hen as a model for ovarian cancer, and demonstrate for the first time the high expression of COX-1 in POF-1 which is the source of prostaglandins needed for oviposition.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18498063      PMCID: PMC4445833          DOI: 10.1007/s12020-008-9080-z

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  43 in total

Review 1.  Ovarian surface epithelium: biology, endocrinology, and pathology.

Authors:  N Auersperg; A S Wong; K C Choi; S K Kang; P C Leung
Journal:  Endocr Rev       Date:  2001-04       Impact factor: 19.871

2.  A pilot study of ovarian cancer chemoprevention using medroxyprogesterone acetate in an avian model of spontaneous ovarian carcinogenesis.

Authors:  Mack N Barnes; Wallace D Berry; J Michael J Straughn; Tyler O Kirby; Charles A Leath; Warner K Huh; William E Grizzle; Edward E Partridge
Journal:  Gynecol Oncol       Date:  2002-10       Impact factor: 5.482

3.  Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer.

Authors:  Daniela M Dinulescu; Tan A Ince; Bradley J Quade; Sarah A Shafer; Denise Crowley; Tyler Jacks
Journal:  Nat Med       Date:  2004-12-26       Impact factor: 53.440

4.  Loss of TNF-alpha-regulated COX-2 expression in ovarian cancer cells.

Authors:  Wan-Lin Yang; Isabelle H Roland; Andrew K Godwin; Xiang-Xi Xu
Journal:  Oncogene       Date:  2005-12-01       Impact factor: 9.867

5.  TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue.

Authors:  D A Kujubu; B S Fletcher; B C Varnum; R W Lim; H R Herschman
Journal:  J Biol Chem       Date:  1991-07-15       Impact factor: 5.157

6.  Ovarian tumor expression of an oviductal protein in the hen: a model for human serous ovarian adenocarcinoma.

Authors:  James R Giles; H L Shivaprasad; Patricia A Johnson
Journal:  Gynecol Oncol       Date:  2004-12       Impact factor: 5.482

7.  Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways.

Authors:  Rong Wu; Neali Hendrix-Lucas; Rork Kuick; Yali Zhai; Donald R Schwartz; Aytekin Akyol; Samir Hanash; David E Misek; Hidetaka Katabuchi; Bart O Williams; Eric R Fearon; Kathleen R Cho
Journal:  Cancer Cell       Date:  2007-04       Impact factor: 31.743

8.  Oxidative damage to DNA of ovarian surface epithelial cells affected by ovulation: carcinogenic implication and chemoprevention.

Authors:  William J Murdoch; James F Martinchick
Journal:  Exp Biol Med (Maywood)       Date:  2004-06

9.  Ovarian tumors of the hen.

Authors:  T N Fredrickson
Journal:  Environ Health Perspect       Date:  1987-08       Impact factor: 9.031

Review 10.  Animal models of ovarian cancer.

Authors:  Barbara C Vanderhyden; Tanya J Shaw; Jean-François Ethier
Journal:  Reprod Biol Endocrinol       Date:  2003-10-07       Impact factor: 5.211

View more
  24 in total

Review 1.  Epithelial ovarian cancer experimental models.

Authors:  E Lengyel; J E Burdette; H A Kenny; D Matei; J Pilrose; P Haluska; K P Nephew; D B Hales; M S Stack
Journal:  Oncogene       Date:  2013-08-12       Impact factor: 9.867

2.  Flaxseed reduces the pro-carcinogenic micro-environment in the ovaries of normal hens by altering the PG and oestrogen pathways in a dose-dependent manner.

Authors:  Anushka Dikshit; Manoel Adrião Gomes Filho; Erfan Eilati; Stacey McGee; Carrie Small; Chunqi Gao; Thomas Klug; Dale Buchanan Hales
Journal:  Br J Nutr       Date:  2015-04-08       Impact factor: 3.718

3.  Contrast-enhanced sonography depicts spontaneous ovarian cancer at early stages in a preclinical animal model.

Authors:  Animesh Barua; Pincas Bitterman; Janice M Bahr; Sanjib Basu; Eyal Sheiner; Michael J Bradaric; Dale B Hales; Judith L Luborsky; Jacques S Abramowicz
Journal:  J Ultrasound Med       Date:  2011-03       Impact factor: 2.153

4.  Matrix metalloproteinase 3 is a stromal marker for chicken ovarian cancer.

Authors:  Jin Won Choi; Suzie E Ahn; Deivendran Rengaraj; Hee Won Seo; Whasun Lim; Gwonhwa Song; Jae Yong Han
Journal:  Oncol Lett       Date:  2011-08-19       Impact factor: 2.967

5.  The hen as a model of ovarian cancer.

Authors:  Patricia A Johnson; James R Giles
Journal:  Nat Rev Cancer       Date:  2013-05-16       Impact factor: 60.716

6.  Long term consumption of flaxseed enriched diet decreased ovarian cancer incidence and prostaglandin E₂in hens.

Authors:  Erfan Eilati; Janice M Bahr; Dale Buchanan Hales
Journal:  Gynecol Oncol       Date:  2013-05-23       Impact factor: 5.482

7.  Effects of cyclooxygenase inhibitors on survival time in ovarian cancer xenograft-bearing mice.

Authors:  Wei Li; Xiao-Li Xu; Jun Zhang; Jia-Hui Cai; Yun-Xian Tang
Journal:  Oncol Lett       Date:  2012-09-20       Impact factor: 2.967

8.  E-cadherin expression in ovarian cancer in the laying hen, Gallus domesticus, compared to human ovarian cancer.

Authors:  Kristine Ansenberger; Yan Zhuge; Jo Ann J Lagman; Cassandra Richards; Animesh Barua; Janice M Bahr; Dale Buchanan Hales
Journal:  Gynecol Oncol       Date:  2009-03-24       Impact factor: 5.482

9.  CYP1B1 expression in ovarian cancer in the laying hen Gallusdomesticus.

Authors:  Yan Zhuge; Jo Ann J Lagman; Kristine Ansenberger; Cassandra J Mahon; Takiko Daikoku; Sudhansu K Dey; Janice M Bahr; Dale B Hales
Journal:  Gynecol Oncol       Date:  2008-10-29       Impact factor: 5.482

10.  Age dependent increase in prostaglandin pathway coincides with onset of ovarian cancer in laying hens.

Authors:  Erfan Eilati; Lurui Pan; Janice M Bahr; Dale Buchanan Hales
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2012-10-23       Impact factor: 4.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.